All In MedTech

Device Trial Radar · NCT06167733

Safety and Efficacy of the VERTICA® RF Device for the Treatment of ED

Safety and Efficacy Assessment of the VERTICA® - a Radio Frequency Device for the Treatment of Erectile Dysfunction

Last checked: Nov 19, 2026Latest source record: Sep 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 201 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

201

Actual

Start

Nov 29, 2023

Primary completion

Sep 21, 2026

Study completion Dec 31, 2026

Sponsor

Lead sponsor
OHH-MED Medical LtdNot on our public-company list
Sponsor type
Industry
First posted
Dec 12, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Male only, from 22 years, up to 85 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Adult subjects with mild to moderate and moderate ED who meet the study eligibility criteria will be enrolled in the study. The enrolled subjects will be randomized by a 1:1 ratio to receive the Active or Sham VERTICA® treatment. Baseline assessments will include collection of demographic data, medical history, concomitant medications and baseline clinical examinations. The initial treatment session will be performed in a clinical setting simulating home use to determine proper device use and to evaluate device tolerability, followed by continued home use of the device for a total of 6 months. Patients will be instructed to attempt sexual activity periodically over the course of the study. Every time a sexual intercourse is attempted, the patient will be requested to complete an event log using validated assessments. Patients will present for monthly follow-up visits, during which safety will be evaluated and additional efficacy assessments will be performed.

Conditions

  • Erectile Dysfunction

Interventions

  • VERTICA Active deviceDevice

    VERTICA device with a therapeutic RF energy level

  • VERTICA Sham deviceDevice

    VERTICA device with a low, non-therapeutic RF energy level

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. A significant difference in the mean change from baseline in the International Index of Erectile Function - Erectile Function domain (IIEF-EF) scores at 12 weeks, between the treatment groups.Time frame: 12 weeks
  2. A significant change from baseline in the mean International Index of Erectile Function - Erectile Function domain (IIEF-EF) scores at 12 weeks, within the VERTICA Active treatment group.Time frame: 12 weeks

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • University of California, Irvine Medical Center

    Newport Beach, California

  • San Diego Sexual Medicine

    San Diego, California

  • Optimal Health Miami

    Aventura, Florida

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.